OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Consensus on potential biomarkers developed for use in clinical tests for schizophrenia
Ping Lin, Junyu Sun, Xiaoyan Lou, et al.
General Psychiatry (2022) Vol. 35, Iss. 1, pp. e100685-e100685
Open Access | Times Cited: 25

Showing 25 citing articles:

Association of serum homocysteine levels with intestinal flora and cognitive function in schizophrenia
Hehua Li, Hanqiu Li, Zhimin Zhu, et al.
Journal of Psychiatric Research (2023) Vol. 159, pp. 258-265
Closed Access | Times Cited: 15

A new era for schizophrenia drug development – Lessons for the future
Kiri Granger, Michael Sand, Sheryl Caswell, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 7, pp. 103603-103603
Open Access | Times Cited: 14

Biomarkers of endogenous mental disorders: the role of cortisol, extracellular DNA, BDNF, and cytokines in relation to disease stage and therapy
M. V. Kuzminova, Е. В. Семина, Y. A. Chayka
Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) (2025), Iss. 2, pp. 245-258
Closed Access

Current perspectives on the recognition and management of treatment-resistant schizophrenia: challenges and opportunities
Myrto Samara, Georgios Alevizopoulos, Vasilis P. Bozikasc, et al.
Expert Review of Neurotherapeutics (2025)
Closed Access

Intricate role of intestinal microbe and metabolite in schizophrenia
Shi Li, Peijun Ju, Xiaojing Meng, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9

Dysregulation of interleukin-8 is involved in the onset and relapse of schizophrenia: An independent validation and meta-analysis
Junwei Yan, Qingrong Xia, Xuejun Sun, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 133, pp. 111018-111018
Closed Access | Times Cited: 3

Diminished functional segregation and resilience are associated with symptomatic severity and cognitive impairments in schizophrenia: a large-scale study
Haohao Yan, Yiding Han, Xijia Xu, et al.
General Psychiatry (2024) Vol. 37, Iss. 5, pp. e101613-e101613
Open Access | Times Cited: 2

Dysregulation of Serum Exosomal Lipid Metabolism in Schizophrenia: A Biomarker Perspective
Chenxi Xu, Wei Huang, Xiaojie Shi, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 2

Apolipoprotein D as a Potential Biomarker in Neuropsychiatric Disorders
Eva del Valle, Núria Rubio-Sardón, Carlota Menéndez-Pérez, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15631-15631
Open Access | Times Cited: 5

Common susceptibility variants ofKDRandIGF-1Rare associated with poststroke depression in the Chinese population
Yingying Yue, Linlin You, Fuying Zhao, et al.
General Psychiatry (2023) Vol. 36, Iss. 1, pp. e100928-e100928
Open Access | Times Cited: 4

Automatic Thoughts, Self-Stigma, and Resilience Among Schizophrenia Patients with Metabolic Syndrome: A Cross-Sectional Study
Shenglan Ma, Peijun Ju, Qingrong Xia, et al.
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 1195-1206
Open Access | Times Cited: 4

Identification of Immune-Linked Hub Genes and Diagnostic Model Construction in Schizophrenia
Kun Lian, Zonglin Shen, Runxu Yang, et al.
Journal of Molecular Neuroscience (2023) Vol. 73, Iss. 7-8, pp. 635-648
Open Access | Times Cited: 4

Potential Inflammatory Biomarker in Patients with Attention Deficit Hyperactivity Disorder
Ji Hyun Park
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13054-13054
Open Access | Times Cited: 7

A Potential Immune-Related miRNAs Regulatory Network and Corresponding Diagnostic Efficacy in Schizophrenia
Fangping Liao, Qingqing Zhong, Xueying Liang, et al.
Neurochemical Research (2023) Vol. 48, Iss. 9, pp. 2784-2793
Closed Access | Times Cited: 2

Biomarkers
Margareth Borges Coutinho Gallo
(2024), pp. 13-36
Closed Access

Biological Characteristics of Treatment Outcomes in Schizophrenia
Manul Das, Sohini Chakraborty, Nabagata Das, et al.
Springer eBooks (2024), pp. 1-30
Closed Access

Peripheral molecular and brain structural profile implicated stress activation and hyperoxidation in methamphetamine use disorder
Hang Su, Weichen Song, Qiming Lv, et al.
Psychiatry and Clinical Neurosciences (2024)
Closed Access

Extended range proteomic analysis of blood plasma from schizophrenia patients
Denis V. Petrovskiy, Tatiana V. Butkova, Kirill S. Nikolsky, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access

Digital-palmar dermatoglyphics characteristics of patients living with schizophrenia in Ghana
Niena Samira Majeed, Benjamin Arko‐Boham, Delali Fiagbe, et al.
All Life (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 1

The Effectiveness of Meloxicam Adjuvant Therapy against Negative Symptoms and Neutrophil Lymphocyte Ratio (NLR) in Schizophrenic Patients
Katarina Bernadet Dinda Sekar Melati, Adriesti Hardaetha, Wijaya Kusuma
JUXTA Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga (2023) Vol. 14, Iss. 2, pp. 57-62
Open Access | Times Cited: 1

Prospecting the Intricate Role of Intestinal Microbe and Microbial Metabolite Biomarkers in Schizophrenia
Shi Li, Peijun Ju, Xiaojing Meng, et al.
Research Square (Research Square) (2023)
Open Access

Page 1

Scroll to top